Global Oncology Biomarker Market Research Report 2023

October 2023 | 89 pages | ID: G53089425CF2EN
QYResearch

Abstracts

This report aims to provide a comprehensive presentation of the global market for Oncology Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Biomarker.

The Oncology Biomarker market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Oncology Biomarker market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oncology Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

• Abbott Laboratories
• Bristol-Myers Squibb
• Eli Lilly and Company
• F.Hoffmann-La Roche Ltd.
• Genomic Health
• GlaxoSmithKline plc
• Novartis AG
• Merck & Co.
• Pfizer
• Qiagen N.V.

Segment by Type

• Lung Cancer
• Breast Cancer
• Colorectal Cancer
• Prostate Cancer
• Stomach Cancer
• Others

Segment by Application

• Diagnostics
• Drug Discovery And Development
• Prognostics
• Risk Assessment
• Others

By Region

• North America
• United States
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Nordic Countries
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oncology Biomarker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Oncology Biomarker Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
  1.2.2 Lung Cancer
  1.2.3 Breast Cancer
  1.2.4 Colorectal Cancer
  1.2.5 Prostate Cancer
  1.2.6 Stomach Cancer
  1.2.7 Others
1.3 Market by Application
  1.3.1 Global Oncology Biomarker Market Growth by Application: 2018 VS 2022 VS 2029
  1.3.2 Diagnostics
  1.3.3 Drug Discovery And Development
  1.3.4 Prognostics
  1.3.5 Risk Assessment
  1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Oncology Biomarker Market Perspective (2018-2029)
2.2 Oncology Biomarker Growth Trends by Region
  2.2.1 Global Oncology Biomarker Market Size by Region: 2018 VS 2022 VS 2029
  2.2.2 Oncology Biomarker Historic Market Size by Region (2018-2023)
  2.2.3 Oncology Biomarker Forecasted Market Size by Region (2024-2029)
2.3 Oncology Biomarker Market Dynamics
  2.3.1 Oncology Biomarker Industry Trends
  2.3.2 Oncology Biomarker Market Drivers
  2.3.3 Oncology Biomarker Market Challenges
  2.3.4 Oncology Biomarker Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Oncology Biomarker Players by Revenue
  3.1.1 Global Top Oncology Biomarker Players by Revenue (2018-2023)
  3.1.2 Global Oncology Biomarker Revenue Market Share by Players (2018-2023)
3.2 Global Oncology Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncology Biomarker Revenue
3.4 Global Oncology Biomarker Market Concentration Ratio
  3.4.1 Global Oncology Biomarker Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Oncology Biomarker Revenue in 2022
3.5 Oncology Biomarker Key Players Head office and Area Served
3.6 Key Players Oncology Biomarker Product Solution and Service
3.7 Date of Enter into Oncology Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans

4 ONCOLOGY BIOMARKER BREAKDOWN DATA BY TYPE

4.1 Global Oncology Biomarker Historic Market Size by Type (2018-2023)
4.2 Global Oncology Biomarker Forecasted Market Size by Type (2024-2029)

5 ONCOLOGY BIOMARKER BREAKDOWN DATA BY APPLICATION

5.1 Global Oncology Biomarker Historic Market Size by Application (2018-2023)
5.2 Global Oncology Biomarker Forecasted Market Size by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Oncology Biomarker Market Size (2018-2029)
6.2 North America Oncology Biomarker Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Oncology Biomarker Market Size by Country (2018-2023)
6.4 North America Oncology Biomarker Market Size by Country (2024-2029)
6.5 United States
6.6 Canada

7 EUROPE

7.1 Europe Oncology Biomarker Market Size (2018-2029)
7.2 Europe Oncology Biomarker Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Oncology Biomarker Market Size by Country (2018-2023)
7.4 Europe Oncology Biomarker Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries

8 ASIA-PACIFIC

8.1 Asia-Pacific Oncology Biomarker Market Size (2018-2029)
8.2 Asia-Pacific Oncology Biomarker Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Oncology Biomarker Market Size by Region (2018-2023)
8.4 Asia-Pacific Oncology Biomarker Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia

9 LATIN AMERICA

9.1 Latin America Oncology Biomarker Market Size (2018-2029)
9.2 Latin America Oncology Biomarker Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Oncology Biomarker Market Size by Country (2018-2023)
9.4 Latin America Oncology Biomarker Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Oncology Biomarker Market Size (2018-2029)
10.2 Middle East & Africa Oncology Biomarker Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Oncology Biomarker Market Size by Country (2018-2023)
10.4 Middle East & Africa Oncology Biomarker Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE

11 KEY PLAYERS PROFILES

11.1 Abbott Laboratories
  11.1.1 Abbott Laboratories Company Detail
  11.1.2 Abbott Laboratories Business Overview
  11.1.3 Abbott Laboratories Oncology Biomarker Introduction
  11.1.4 Abbott Laboratories Revenue in Oncology Biomarker Business (2018-2023)
  11.1.5 Abbott Laboratories Recent Development
11.2 Bristol-Myers Squibb
  11.2.1 Bristol-Myers Squibb Company Detail
  11.2.2 Bristol-Myers Squibb Business Overview
  11.2.3 Bristol-Myers Squibb Oncology Biomarker Introduction
  11.2.4 Bristol-Myers Squibb Revenue in Oncology Biomarker Business (2018-2023)
  11.2.5 Bristol-Myers Squibb Recent Development
11.3 Eli Lilly and Company
  11.3.1 Eli Lilly and Company Company Detail
  11.3.2 Eli Lilly and Company Business Overview
  11.3.3 Eli Lilly and Company Oncology Biomarker Introduction
  11.3.4 Eli Lilly and Company Revenue in Oncology Biomarker Business (2018-2023)
  11.3.5 Eli Lilly and Company Recent Development
11.4 F.Hoffmann-La Roche Ltd.
  11.4.1 F.Hoffmann-La Roche Ltd. Company Detail
  11.4.2 F.Hoffmann-La Roche Ltd. Business Overview
  11.4.3 F.Hoffmann-La Roche Ltd. Oncology Biomarker Introduction
  11.4.4 F.Hoffmann-La Roche Ltd. Revenue in Oncology Biomarker Business (2018-2023)
  11.4.5 F.Hoffmann-La Roche Ltd. Recent Development
11.5 Genomic Health
  11.5.1 Genomic Health Company Detail
  11.5.2 Genomic Health Business Overview
  11.5.3 Genomic Health Oncology Biomarker Introduction
  11.5.4 Genomic Health Revenue in Oncology Biomarker Business (2018-2023)
  11.5.5 Genomic Health Recent Development
11.6 GlaxoSmithKline plc
  11.6.1 GlaxoSmithKline plc Company Detail
  11.6.2 GlaxoSmithKline plc Business Overview
  11.6.3 GlaxoSmithKline plc Oncology Biomarker Introduction
  11.6.4 GlaxoSmithKline plc Revenue in Oncology Biomarker Business (2018-2023)
  11.6.5 GlaxoSmithKline plc Recent Development
11.7 Novartis AG
  11.7.1 Novartis AG Company Detail
  11.7.2 Novartis AG Business Overview
  11.7.3 Novartis AG Oncology Biomarker Introduction
  11.7.4 Novartis AG Revenue in Oncology Biomarker Business (2018-2023)
  11.7.5 Novartis AG Recent Development
11.8 Merck & Co.
  11.8.1 Merck & Co. Company Detail
  11.8.2 Merck & Co. Business Overview
  11.8.3 Merck & Co. Oncology Biomarker Introduction
  11.8.4 Merck & Co. Revenue in Oncology Biomarker Business (2018-2023)
  11.8.5 Merck & Co. Recent Development
11.9 Pfizer
  11.9.1 Pfizer Company Detail
  11.9.2 Pfizer Business Overview
  11.9.3 Pfizer Oncology Biomarker Introduction
  11.9.4 Pfizer Revenue in Oncology Biomarker Business (2018-2023)
  11.9.5 Pfizer Recent Development
11.10 Qiagen N.V.
  11.10.1 Qiagen N.V. Company Detail
  11.10.2 Qiagen N.V. Business Overview
  11.10.3 Qiagen N.V. Oncology Biomarker Introduction
  11.10.4 Qiagen N.V. Revenue in Oncology Biomarker Business (2018-2023)
  11.10.5 Qiagen N.V. Recent Development

12 ANALYST'S VIEWPOINTS/CONCLUSIONS


13 APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Global Oncology Biomarker Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Lung Cancer
Table 3. Key Players of Breast Cancer
Table 4. Key Players of Colorectal Cancer
Table 5. Key Players of Prostate Cancer
Table 6. Key Players of Stomach Cancer
Table 7. Key Players of Others
Table 8. Global Oncology Biomarker Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Oncology Biomarker Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Oncology Biomarker Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Oncology Biomarker Market Share by Region (2018-2023)
Table 12. Global Oncology Biomarker Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 13. Global Oncology Biomarker Market Share by Region (2024-2029)
Table 14. Oncology Biomarker Market Trends
Table 15. Oncology Biomarker Market Drivers
Table 16. Oncology Biomarker Market Challenges
Table 17. Oncology Biomarker Market Restraints
Table 18. Global Oncology Biomarker Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Oncology Biomarker Market Share by Players (2018-2023)
Table 20. Global Top Oncology Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Biomarker as of 2022)
Table 21. Ranking of Global Top Oncology Biomarker Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Oncology Biomarker Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Oncology Biomarker Product Solution and Service
Table 25. Date of Enter into Oncology Biomarker Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Oncology Biomarker Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Oncology Biomarker Revenue Market Share by Type (2018-2023)
Table 29. Global Oncology Biomarker Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 30. Global Oncology Biomarker Revenue Market Share by Type (2024-2029)
Table 31. Global Oncology Biomarker Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Oncology Biomarker Revenue Market Share by Application (2018-2023)
Table 33. Global Oncology Biomarker Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 34. Global Oncology Biomarker Revenue Market Share by Application (2024-2029)
Table 35. North America Oncology Biomarker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Oncology Biomarker Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Oncology Biomarker Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Oncology Biomarker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. Europe Oncology Biomarker Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Oncology Biomarker Market Size by Country (2024-2029) & (US$ Million)
Table 41. Asia-Pacific Oncology Biomarker Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 42. Asia-Pacific Oncology Biomarker Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Oncology Biomarker Market Size by Region (2024-2029) & (US$ Million)
Table 44. Latin America Oncology Biomarker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Latin America Oncology Biomarker Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Oncology Biomarker Market Size by Country (2024-2029) & (US$ Million)
Table 47. Middle East & Africa Oncology Biomarker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Middle East & Africa Oncology Biomarker Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Oncology Biomarker Market Size by Country (2024-2029) & (US$ Million)
Table 50. Abbott Laboratories Company Detail
Table 51. Abbott Laboratories Business Overview
Table 52. Abbott Laboratories Oncology Biomarker Product
Table 53. Abbott Laboratories Revenue in Oncology Biomarker Business (2018-2023) & (US$ Million)
Table 54. Abbott Laboratories Recent Development
Table 55. Bristol-Myers Squibb Company Detail
Table 56. Bristol-Myers Squibb Business Overview
Table 57. Bristol-Myers Squibb Oncology Biomarker Product
Table 58. Bristol-Myers Squibb Revenue in Oncology Biomarker Business (2018-2023) & (US$ Million)
Table 59. Bristol-Myers Squibb Recent Development
Table 60. Eli Lilly and Company Company Detail
Table 61. Eli Lilly and Company Business Overview
Table 62. Eli Lilly and Company Oncology Biomarker Product
Table 63. Eli Lilly and Company Revenue in Oncology Biomarker Business (2018-2023) & (US$ Million)
Table 64. Eli Lilly and Company Recent Development
Table 65. F.Hoffmann-La Roche Ltd. Company Detail
Table 66. F.Hoffmann-La Roche Ltd. Business Overview
Table 67. F.Hoffmann-La Roche Ltd. Oncology Biomarker Product
Table 68. F.Hoffmann-La Roche Ltd. Revenue in Oncology Biomarker Business (2018-2023) & (US$ Million)
Table 69. F.Hoffmann-La Roche Ltd. Recent Development
Table 70. Genomic Health Company Detail
Table 71. Genomic Health Business Overview
Table 72. Genomic Health Oncology Biomarker Product
Table 73. Genomic Health Revenue in Oncology Biomarker Business (2018-2023) & (US$ Million)
Table 74. Genomic Health Recent Development
Table 75. GlaxoSmithKline plc Company Detail
Table 76. GlaxoSmithKline plc Business Overview
Table 77. GlaxoSmithKline plc Oncology Biomarker Product
Table 78. GlaxoSmithKline plc Revenue in Oncology Biomarker Business (2018-2023) & (US$ Million)
Table 79. GlaxoSmithKline plc Recent Development
Table 80. Novartis AG Company Detail
Table 81. Novartis AG Business Overview
Table 82. Novartis AG Oncology Biomarker Product
Table 83. Novartis AG Revenue in Oncology Biomarker Business (2018-2023) & (US$ Million)
Table 84. Novartis AG Recent Development
Table 85. Merck & Co. Company Detail
Table 86. Merck & Co. Business Overview
Table 87. Merck & Co. Oncology Biomarker Product
Table 88. Merck & Co. Revenue in Oncology Biomarker Business (2018-2023) & (US$ Million)
Table 89. Merck & Co. Recent Development
Table 90. Pfizer Company Detail
Table 91. Pfizer Business Overview
Table 92. Pfizer Oncology Biomarker Product
Table 93. Pfizer Revenue in Oncology Biomarker Business (2018-2023) & (US$ Million)
Table 94. Pfizer Recent Development
Table 95. Qiagen N.V. Company Detail
Table 96. Qiagen N.V. Business Overview
Table 97. Qiagen N.V. Oncology Biomarker Product
Table 98. Qiagen N.V. Revenue in Oncology Biomarker Business (2018-2023) & (US$ Million)
Table 99. Qiagen N.V. Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Oncology Biomarker Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Oncology Biomarker Market Share by Type: 2022 VS 2029
Figure 3. Lung Cancer Features
Figure 4. Breast Cancer Features
Figure 5. Colorectal Cancer Features
Figure 6. Prostate Cancer Features
Figure 7. Stomach Cancer Features
Figure 8. Others Features
Figure 9. Global Oncology Biomarker Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Oncology Biomarker Market Share by Application: 2022 VS 2029
Figure 11. Diagnostics Case Studies
Figure 12. Drug Discovery And Development Case Studies
Figure 13. Prognostics Case Studies
Figure 14. Risk Assessment Case Studies
Figure 15. Others Case Studies
Figure 16. Oncology Biomarker Report Years Considered
Figure 17. Global Oncology Biomarker Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 18. Global Oncology Biomarker Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global Oncology Biomarker Market Share by Region: 2022 VS 2029
Figure 20. Global Oncology Biomarker Market Share by Players in 2022
Figure 21. Global Top Oncology Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Biomarker as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by Oncology Biomarker Revenue in 2022
Figure 23. North America Oncology Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America Oncology Biomarker Market Share by Country (2018-2029)
Figure 25. United States Oncology Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Oncology Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Oncology Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Oncology Biomarker Market Share by Country (2018-2029)
Figure 29. Germany Oncology Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Oncology Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Oncology Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Oncology Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Oncology Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Oncology Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Oncology Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Oncology Biomarker Market Share by Region (2018-2029)
Figure 37. China Oncology Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Japan Oncology Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. South Korea Oncology Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Oncology Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. India Oncology Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Australia Oncology Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Oncology Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Oncology Biomarker Market Share by Country (2018-2029)
Figure 45. Mexico Oncology Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Brazil Oncology Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Oncology Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Oncology Biomarker Market Share by Country (2018-2029)
Figure 49. Turkey Oncology Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Oncology Biomarker Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Abbott Laboratories Revenue Growth Rate in Oncology Biomarker Business (2018-2023)
Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Oncology Biomarker Business (2018-2023)
Figure 53. Eli Lilly and Company Revenue Growth Rate in Oncology Biomarker Business (2018-2023)
Figure 54. F.Hoffmann-La Roche Ltd. Revenue Growth Rate in Oncology Biomarker Business (2018-2023)
Figure 55. Genomic Health Revenue Growth Rate in Oncology Biomarker Business (2018-2023)
Figure 56. GlaxoSmithKline plc Revenue Growth Rate in Oncology Biomarker Business (2018-2023)
Figure 57. Novartis AG Revenue Growth Rate in Oncology Biomarker Business (2018-2023)
Figure 58. Merck & Co. Revenue Growth Rate in Oncology Biomarker Business (2018-2023)
Figure 59. Pfizer Revenue Growth Rate in Oncology Biomarker Business (2018-2023)
Figure 60. Qiagen N.V. Revenue Growth Rate in Oncology Biomarker Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed